companydata.dkcompanydata.dk

Scandion Oncology A/S: Financial statements 2018

CVR: 38613391

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Scandion Oncology A/S (CVR 38613391) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -7,385,008 and a net result of DKK -8,182,558. Equity in the 2018 report amounted to DKK 12,570,107. The solvency ratio was 92.7%. The company had 2 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -7,385,008
Profit/Loss
DKK -8,182,558
Equity
DKK 12,570,107
Total Assets
DKK 13,562,750
Employees
2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Nils Aage Brünner joins Scandion Oncology A/S as adm. dir.Jul 5, 2018

As of July 5, 2018, Nils Aage Brünner is registered as adm. dir. of Scandion Oncology A/S.

Jørgen Vilhelm Løvenørn Bardenfleth joins Scandion Oncology A/S as chairmanJul 5, 2018

As of July 5, 2018, Jørgen Vilhelm Løvenørn Bardenfleth is registered as chairman of Scandion Oncology A/S.

Thomas Feldthus joins Scandion Oncology A/S as vice chairmanJul 5, 2018

As of July 5, 2018, Thomas Feldthus is registered as vice chairman of Scandion Oncology A/S.

Kim Arvid Nielsen steps down as adm. dir. of Scandion Oncology A/SJul 5, 2018

As of July 5, 2018, Kim Arvid Nielsen has stepped down as adm. dir. of Scandion Oncology A/S.

Nils Aage Brünner steps down as chairman of Scandion Oncology A/SJul 5, 2018

As of July 5, 2018, Nils Aage Brünner has stepped down as chairman of Scandion Oncology A/S.

Jørgen Vilhelm Løvenørn Bardenfleth leaves the board of Scandion Oncology A/SJul 4, 2018

As of July 4, 2018, Jørgen Vilhelm Løvenørn Bardenfleth has left the board of directors of Scandion Oncology A/S.

Scandion Oncology A/S publishes interim reportApr 4, 2018

Scandion Oncology A/S has published its interim report for the period May 2, 2017 to December 31, 2017.

About Scandion Oncology A/S

Scandion Oncology A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2017. The company has been dissolved on 6 October 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -6,100,000 and a net result of DKK -8,286,000. Equity in the 2025 report amounted to DKK 0.

Source: annual report 2025, Danish Business Authority

Other financial years